Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 25;11(3):353.
doi: 10.3390/biom11030353.

SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?

Yuqing Zhang  1   2   3 , Shailendra Anoopkumar-Dukie  1   2   3 , Andrew Keith Davey  1   2   3
Affiliations
Review

SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?

Yuqing Zhang et al. Biomolecules. .

Abstract

Depression is a psychiatric disorder that has a significant health burden on patients and their families. Unfortunately, the current antidepressant medications that mainly target monoamine neurotransmitters have limited efficacy. Recent evidence has indicated that neuroinflammation participates in the genesis and development of depression, and interacts with other factors involved in depression. Therefore, exploring effective anti-inflammatory medications could be beneficial for the development of new treatment options for depression. Sirtuins are a unique class of nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases, which have seven members that can affect multiple downstream targets by deacetylation activity. Among these seven members, SIRT1 and SIRT2 have been shown to participate in the pathophysiology of inflammation in numerous studies. Thus, in this short article, we review the association of SIRT1 and SIRT2 activity and depression, and evidence of the effects of SIRT1 and SIRT2 modulators on inflammation in vitro and depressive-like behaviours in vivo.

Keywords: SIRT1; SIRT2; clinical study; depression; inflammation; polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pathways through which SIRT1, SIRT2 modulators could potentially influence depressive- and anxiety-like behaviours.
See this image and copyright information in PMC

References

    1. Murray C.J.L., Lopez A.D. The Global Burden of Disease. Harvard School of Public Health on behalf of the World Health Organization and the World Bank; Boston, MA, USA: 1996. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020.
    1. World Health Organization Depression Key Facts. [(accessed on 20 November 2020)]; Available online: https://www.who.int/news-room/fact-sheets/detail/depression.
    1. Roy A., Campbell M.K. A unifying framework for depression: Bridging the major biological and psychosocial theories through stress. Clin. Investig. Med. 2013;36:170–E190. doi: 10.25011/cim.v36i4.19951. - DOI - PubMed
    1. Kohler O., Krogh J., Mors O., Benros M.E. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. Curr. Neuropharmacol. 2016;14:732–742. doi: 10.2174/1570159X14666151208113700. - DOI - PMC - PubMed
    1. Loonen A.J.M., Ivanova S.A. Circuits Regulating Pleasure and Happiness—Mechanisms of Depression. Front. Hum. Neurosci. 2016;10:571. doi: 10.3389/fnhum.2016.00571. - DOI - PMC - PubMed

LinkOut - more resources